These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 26377981

  • 1. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W, Gołąb-Janowska M, Safranow K, Rotter I, Amernik K, Honczarenko K, Nowacki P.
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U, Kaldonska M, Klodowska-Duda G, Wyska E, Safranow K, Bialecka M, Gawronska-Szklarz B.
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [Abstract] [Full Text] [Related]

  • 3. Speech rate in Parkinson's disease: A controlled study.
    Martínez-Sánchez F, Meilán JJ, Carro J, Gómez Íñiguez C, Millian-Morell L, Pujante Valverde IM, López-Alburquerque T, López DE.
    Neurologia; 2016 Sep; 31(7):466-72. PubMed ID: 25660139
    [Abstract] [Full Text] [Related]

  • 4. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P.
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [Abstract] [Full Text] [Related]

  • 5. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P.
    J Parkinsons Dis; 2018 Feb; 8(1):59-70. PubMed ID: 29480220
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Speech dysfunction in early Parkinson's disease.
    Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, Brin MF.
    Mov Disord; 1995 Sep; 10(5):562-5. PubMed ID: 8552106
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM.
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F.
    Rev Neurol; 2010 Nov 01; 51(9):542-50. PubMed ID: 20979034
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. For better or worse: The effect of levodopa on speech in Parkinson's disease.
    Ho AK, Bradshaw JL, Iansek R.
    Mov Disord; 2008 Mar 15; 23(4):574-80. PubMed ID: 18163453
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J, Tykalová T, Krupička R, Zárubová K, Novotný M, Jech R, Szabó Z, Růžička E.
    J Neural Transm (Vienna); 2017 Apr 15; 124(4):463-470. PubMed ID: 27933492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.